This inventor holds 1 USPTO granted patent. Top assignee: Arzneimittelwerk Dresden Gmbh. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Yekaterina K Grigoryeva: Innovator in Antiarrhythmic and Anticholinergic Drug Development
Introduction
Yekaterina K Grigoryeva is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs for treating antiarrhythmia and as anticholinergic agents. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to improving healthcare.
Latest Patents
Yekaterina holds a patent for the invention titled "5-(1-aminoacyl)-5,10-dihydro-11H-dibenzo[b,e](1,4)diazepin-11-ones - 5-(w-Aminoacyl)-5,10-dihydro-11H-dibenzo(b,e)(1,4)-diazepine-11-ones, and their preparation." This patent is particularly noteworthy as it addresses the treatment of antiarrhythmia and provides a novel approach to anticholinergic drug development. She has 1 patent to her name, reflecting her innovative contributions to the pharmaceutical industry.
Career Highlights
Yekaterina is currently employed at Arzneimittelwerk Dresden GmbH, where she continues to advance her research and development efforts. Her work at this esteemed company allows her to collaborate with other talented professionals in the field, further enhancing her impact on drug development.
Collaborations
Throughout her career, Yekaterina has worked alongside notable colleagues, including Carla Ruger and Wolfgang Sauer. These collaborations have enriched her research and contributed to the successful development of her patented inventions.
Conclusion
Yekaterina K Grigoryeva is a remarkable inventor whose work in the pharmaceutical industry has the potential to significantly improve treatment options for patients. Her dedication to innovation and collaboration exemplifies the spirit of progress in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile